Urine Biomarkers Can Outperform Serum Biomarkers in Certain Diseases
Researchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read MorePosted by Andy Lundin | Nov 1, 2023 | Urinalysis & Toxicology |
Researchers reported the enhanced performance of urinary biomarkers compared to plasma biomarkers for disease detection.
Read MorePosted by Andy Lundin | Nov 1, 2023 | Cancer |
Researchers developed a highly sensitive blood test that detects a key protein produced by cancer cells, showing promise for early detection.
Read MorePosted by Andy Lundin | Oct 30, 2023 | Cancer, Digital Pathology |
Roche is collaborating with Ibex and AWS to enable pathology labs to access AI-powered decision support tools to support cancer diagnosis.
Read MorePosted by Andy Lundin | Oct 24, 2023 | Cancer |
Researchers detected cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with a high risk of developing cancer.
Read MorePosted by Andy Lundin | Oct 16, 2023 | Prostate |
ArteraAI will present data demonstrating the successful validation of its prognostic model in advanced prostate cancer.
Read More